| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ALZN | Common Stock | Purchase | $5,092 | +5,000 | +0.65% | $1.02 | 768,365 | 05 Jan 2024 | By Ault Lending, LLC | F1, F2 |
| holding | ALZN | Common Stock | 166,865 | 05 Jan 2024 | Direct | ||||||
| holding | ALZN | Common Stock | 996,197 | 05 Jan 2024 | By Ault Life Sciences, Inc. | F3 | |||||
| holding | ALZN | Common Stock | 666,665 | 05 Jan 2024 | By Ault Life Sciences Fund, LLC | F4 |
| Id | Content |
|---|---|
| F1 | Includes 26,032 shares of common stock previously owned by, and received from, Ault Alpha LP ("Ault Alpha"), in connection with the liquidation of Ault Alpha on December 28, 2023. Those 26,032 shares were previously reported as beneficially owned by Mr. Ault as Ault Alpha also reported as an indirect beneficial ownership under Mr. Ault, so no change in beneficial ownership of those shares occurred in connection with the liquidation. |
| F2 | Ault Lending, LLC ("Ault Lending"), is a wholly-owned subsidiary of Ault Alliance, Inc. ("AAI"). Mr. Ault, the Executive Chairman of AAI, is deemed to have voting and investment power with respect to the securities held of record by Ault Lending. |
| F3 | Mr. Ault has sole voting and investment power with respect to the securities held of record by Ault Life Sciences, Inc. |
| F4 | Mr. Ault has sole voting and investment power with respect to the securities held of record by Ault Life Sciences Fund, LLC. |